Fig. 4From: A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesotheliomaHE staining and IHC staining of tumor tissue from the original patient and PDX2 model (P3). For original tumor: (A) HE staining, (B, C, E, F) CR, WT1, CAM5.2, and VIM positive, (D, G) CK5/6 and DES negative; for PDX1’s tumor: (H) HE staining, (I-K) CR, WT1, CK5/6, CAM5.2 positive (original magnification ×400)Back to article page